Correlating Predicted Adjuvant Therapy Benefit and Risk of Recurrence Between Breast Cancer Index (BCI) and the 21-Gene Oncotype DX Recurrence Score (RS)
Nicole Casasanta, Rima Patel, Samantha Raymond, Melanie W. Kier, Julia Blanter, Sophie Sohval, Malin Hovstadius, Catherine Wu, Brittney Zimmerman, Krystal Cascetta, Emilia Bagiella, Amy Tiersten
Research output: Contribution to journal › Article › peer-review
Fingerprint
Dive into the research topics of 'Correlating Predicted Adjuvant Therapy Benefit and Risk of Recurrence Between Breast Cancer Index (BCI) and the 21-Gene Oncotype DX Recurrence Score (RS)'. Together they form a unique fingerprint.